Nov 16, 2022 | AHA Scientific Session Abstract
AHA Scientific Session Abstract, November 2022 Background In our previous study, we developed a deep-learning-based novel cardiovascular disease (CVD) risk stratification system based on retinal photographs, Reti-CVD. This study aims to further validate Reti-CVD in...Nov 16, 2022 | AHA Scientific Session Abstract
AHA Scientific Session Abstract, November 2022 Introduction Currently in the United Kingdom, cardiovascular disease (CVD) risk assessment is based on the QRISK3 score, with a benchmark of 10% for 10-year CVD risk determining clinical intervention. Yet, effects on...Nov 16, 2022 | AHA Scientific Session Abstract
AHA Scientific Session Abstract, November 2022 Introduction The Korean Ministry of Food and Drug Safety (K-MFDS) has authorized over 110 artificial intelligence (AI)-software as medical devices (AI-SaMDs) for diagnostic purposes. Herein, we clinically validate the...